Halozyme Therapeutics Inc (NASDAQ:HALO)

18.48
Delayed Data
As of Feb 20
 -0.06 / -0.32%
Today’s Change
11.41
Today|||52-Week Range
21.13
-8.79%
Year-to-Date

Today’s Trading

Previous close18.54
Today’s open18.45
Day’s range18.42 - 18.95
Volume1,036,622
Average volume (3 months)1,223,434
Market cap$2.6B
Data as of 4:00pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)+139.74%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+0.31+0.82%
BPMCBlueprint Medicines ...+0.40+0.49%
XLRNAcceleron Pharma Inc+0.58+1.38%
XONIntrexon Corp-0.41-3.09%
Data as of 4:02pm ET, 02/20/2018

Financials

Last reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.72
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts